| CAS ID: | 140616-46-2 |
| Molecular Formula: | C51H63N3O11S |
| Molecular Weight: | 926.1 g/mol |
| Monoisotopic Mass: | 925.4183 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | FLUORESCEIN LISICOL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C51H63N3O11S/c1-26(33-14-15-37-45-38(25-43(59)50(33,37)3)49(2)18-17-31(57)20-27(49)21-40(45)58)7-16-44(60)54-39(46(61)62)6-4-5-19-52-48(66)53-28-8-11-34-32(22-28)47(63)65-51(34)35-12-9-29(55)23-41(35)64-42-24-30(56)10-13-36(42)51/h8-13,22-24,26-27,31,33,37-40,43,45,55-59H,4-7,14-21,25H2,1-3H3,(H,54,60)(H,61,62)(H2,52,53,66)/t26-,27+,31-,33-,37+,38+,39+,40-,43+,45+,49+,50-/m1/s1 | See All |
| InChI Key: | KHNJPPGHIWPDLG-DXNXUNFASA-N | |
| Smiles: | C[C@H](CCC(=O)N[C@@H](CCCCNC(=S)Nc1ccc2c(c1)C(=O)OC23c4ccc(O)cc4Oc5cc(O)ccc35)C(=O)O)[C@H]6CC[C@H]7[C@@H]8[C@H](O)C[C@@H]9C[C@H](O)CC[C@]9(C)[C@H]8C[C@H](O)[C@]67C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00896597 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | May 11, 2009 | Last Verified | August 9, 2010 |
| Sponsor | Norgine | ||
Trial Record 2
| ClinicalTrial ID | NCT00856713 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | March 6, 2009 | Last Verified | March 6, 2009 |
| Sponsor | Norgine | ||
Trial Record 3
| ClinicalTrial ID | NCT00794482 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | November 20, 2008 | Last Verified | October 8, 2009 |
| Sponsor | Norgine | ||
Trial Record 4
| ClinicalTrial ID | NCT00856869 | Disease | Liver fibrosis |
| Phase | Phase 1,Phase 2 | Status | Completed |
| First Received | March 6, 2009 | Last Verified | March 6, 2009 |
| Sponsor | Norgine | ||
| PubChem: | 70697664 |
| ChEMBL: | CHEMBL2107751 |